Photo by bermixstudio from unsplash
To the editor: In a large international cohort of contemporary polycythemia vera (PV) patients[1][1] recruited at diagnosis and treated according to European LeukemiaNet recommendations,[2][2] the postdiagnosis total major thrombosis rate… Click to show full abstract
To the editor: In a large international cohort of contemporary polycythemia vera (PV) patients[1][1] recruited at diagnosis and treated according to European LeukemiaNet recommendations,[2][2] the postdiagnosis total major thrombosis rate was 2.62% patients per year, lower than that reported in the
Keywords:
polycythemia vera;
cytoreductive therapy;
inhibitors cytoreductive;
ace inhibitors;
polycythemia
Journal Title: Blood
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Blood
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!